| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.932 | 0.005 | 0.948 | Antiinflammatory | 0.948 0.004 DBMET02315 0.923 0.005 DBMET00978 | DBMET02315 | |
| 0.903 | 0.004 | 0.903 | Analgesic | 0.777 0.007 DBMET02315 0.889 0.005 DBMET00978 | ||
| 0.625 | 0.005 | 0.625 | Platelet antagonist | 0.605 0.006 DBMET02315 0.578 0.008 DBMET00978 | ||
| 0.598 | 0.004 | 0.855 | Non-steroidal antiinflammatory agent | 0.855 0.003 DBMET02315 0.596 0.004 DBMET00978 | DBMET02315 | |
| 0.543 | 0.005 | 0.543 | Cyclooxygenase 1 inhibitor | 0.383 0.008 DBMET02315 0.535 0.005 DBMET00978 | ||
| 0.526 | 0.008 | 0.526 | Platelet aggregation inhibitor | 0.351 0.025 DBMET02315 0.464 0.012 DBMET00978 | ||
| 0.5 | 0.005 | 0.5 | Mcl-1 antagonist | 0.27 0.029 DBMET02315 0.5 0.005 DBMET00978 | ||
| 0.422 | 0.005 | 0.422 | Interleukin 1b antagonist | 0.268 0.01 DBMET02315 0.376 0.005 DBMET00978 | ||
| 0.455 | 0.045 | 0.542 | Immunosuppressant | 0.542 0.022 DBMET02315 0.446 0.048 DBMET00978 | DBMET02315 | |
| 0.453 | 0.049 | 0.473 | Calcium channel L-type activator | 0.235 0.222 DBMET02315 0.473 0.039 DBMET00978 | DBMET00978 | |
| 0.403 | 0.007 | 0.403 | Cyclooxygenase inhibitor | 0.316 0.015 DBMET02315 0.392 0.008 DBMET00978 | ||
| 0.369 | 0.007 | 0.369 | Interleukin 1 antagonist | 0.22 0.026 DBMET02315 0.334 0.009 DBMET00978 | ||
| 0.327 | 0.008 | 0.327 | GABA C receptor agonist | 0.264 0.012 DBMET00978 | ||
| 0.301 | 0.014 | 0.304 | Acetylcholine M1 receptor antagonist | 0.139 0.086 DBMET02315 0.304 0.014 DBMET00978 | DBMET00978 | |
| 0.285 | 0.015 | 0.285 | Cyclooxygenase 2 inhibitor | 0.203 0.03 DBMET02315 0.274 0.017 DBMET00978 | ||
| 0.307 | 0.054 | 0.315 | Insulysin inhibitor | 0.315 0.05 DBMET00978 | DBMET00978 | |
| 0.266 | 0.014 | 0.266 | Histone deacetylase SIRT1 inhibitor | 0.134 0.076 DBMET02315 0.259 0.015 DBMET00978 | ||
| 0.377 | 0.125 | 0.64 | Apoptosis agonist | 0.64 0.041 DBMET02315 0.429 0.1 DBMET00978 | DBMET02315 | |
| 0.316 | 0.077 | 0.316 | Calcium channel activator | 0.301 0.091 DBMET00978 | ||
| 0.305 | 0.07 | 0.48 | Interleukin 2 agonist | 0.48 0.011 DBMET02315 0.317 0.062 DBMET00978 | DBMET02315 | |
| 0.284 | 0.055 | 0.741 | Angiogenesis stimulant | 0.741 0.004 DBMET02315 0.309 0.046 DBMET00978 | DBMET02315 | |
| 0.306 | 0.087 | 0.522 | Cholesterol antagonist | 0.522 0.029 DBMET02315 0.333 0.072 DBMET00978 | DBMET02315 | |
| 0.344 | 0.127 | 0.688 | Cyclophilin D inhibitor | 0.688 0.015 DBMET02315 0.352 0.121 DBMET00978 | DBMET02315 | |
| 0.227 | 0.027 | 0.257 | Alpha-N-acetylglucosaminidase inhibitor | 0.257 0.022 DBMET02315 0.189 0.037 DBMET00978 | DBMET02315 | |
| 0.286 | 0.099 | 0.403 | Vasodilator, coronary | 0.403 0.034 DBMET02315 0.287 0.098 DBMET00978 | DBMET02315 | |
| 0.281 | 0.102 | 0.625 | Antithrombotic | 0.625 0.014 DBMET02315 0.283 0.1 DBMET00978 | DBMET02315 | |
| 0.32 | 0.143 | 0.32 | 5 Hydroxytryptamine release inhibitor | 0.32 0.144 DBMET00978 | ||
| 0.238 | 0.066 | 0.293 | Interleukin antagonist | 0.293 0.049 DBMET00978 | DBMET00978 | |
| 0.242 | 0.076 | 0.285 | Tyrosine 3 hydroxylase inhibitor | 0.285 0.041 DBMET00978 | DBMET00978 | |
| 0.237 | 0.083 | 0.264 | Superoxide dismutase inhibitor | 0.264 0.066 DBMET00978 | DBMET00978 | |
| 0.201 | 0.051 | 0.201 | 3C-like protease (Human coronavirus) inhibitor | 0.164 0.081 DBMET00978 | ||
| 0.232 | 0.081 | 0.389 | DNA synthesis inhibitor | 0.389 0.023 DBMET02315 0.239 0.074 DBMET00978 | DBMET02315 | |
| 0.154 | 0.005 | 0.154 | Sphingosine 1-phosphate receptor 5 agonist | 0.123 0.006 DBMET00978 | ||
| 0.176 | 0.027 | 0.176 | Sphingosine 1-phosphate receptor 5 antagonist | 0.166 0.038 DBMET00978 | ||
| 0.171 | 0.031 | 0.185 | MAP kinase kinase 4 inhibitor | 0.185 0.021 DBMET00978 | DBMET00978 | |
| 0.323 | 0.184 | 0.323 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.141 | 0.012 | 0.163 | Aldose reductase inhibitor | 0.147 0.011 DBMET02315 0.163 0.01 DBMET00978 | DBMET00978 | |
| 0.133 | 0.004 | 0.133 | Potassium channel subfamily K member 3 blocker | 0.035 0.016 DBMET02315 0.122 0.005 DBMET00978 | ||
| 0.181 | 0.052 | 0.184 | Arachidonic acid antagonist | 0.184 0.049 DBMET00978 | DBMET00978 | |
| 0.125 | 0.005 | 0.125 | Aconitate hydratase inhibitor | 0.081 0.013 DBMET00978 | ||
| 0.221 | 0.102 | 0.341 | Interleukin agonist | 0.341 0.032 DBMET02315 0.207 0.115 DBMET00978 | DBMET02315 | |
| 0.156 | 0.04 | 0.157 | Acetylcholine muscarinic antagonist | 0.157 0.04 DBMET00978 | DBMET00978 | |
| 0.122 | 0.008 | 0.122 | 5-Alpha-reductase inhibitor | 0.11 0.009 DBMET00978 | ||
| 0.128 | 0.017 | 0.168 | Glutamate release inhibitor | 0.168 0.007 DBMET02315 0.119 0.022 DBMET00978 | DBMET02315 | |
| 0.223 | 0.113 | 0.223 | 5 Hydroxytryptamine uptake stimulant | 0.217 0.122 DBMET00978 | ||
| 0.121 | 0.012 | 0.121 | Glycine receptor agonist | 0.099 0.022 DBMET02315 0.111 0.015 DBMET00978 | ||
| 0.208 | 0.1 | 0.315 | Aldehyde oxidase inhibitor | 0.315 0.062 DBMET00978 | DBMET00978 | |
| 0.142 | 0.034 | 0.142 | Antihistaminic | 0.088 0.066 DBMET00978 | ||
| 0.147 | 0.052 | 0.147 | Ca2+-transporting ATPase inhibitor | 0.139 0.079 DBMET02315 0.145 0.058 DBMET00978 | ||
| 0.209 | 0.114 | 0.211 | 5 Hydroxytryptamine release stimulant | 0.184 0.136 DBMET02315 0.211 0.112 DBMET00978 | DBMET00978 | |
| 0.144 | 0.049 | 0.146 | Histone deacetylase class III inhibitor | 0.146 0.047 DBMET00978 | DBMET00978 | |
| 0.126 | 0.036 | 0.126 | Histamine antagonist | 0.073 0.071 DBMET00978 | ||
| 0.215 | 0.127 | 0.215 | Gastrin inhibitor | |||
| 0.185 | 0.106 | 0.193 | Cyclic AMP phosphodiesterase inhibitor | 0.193 0.099 DBMET02315 0.192 0.1 DBMET00978 | DBMET02315 | |
| 0.113 | 0.04 | 0.144 | Alcohol dehydrogenase inhibitor | 0.144 0.022 DBMET00978 | DBMET00978 | |
| 0.077 | 0.004 | 0.077 | Follicle-stimulating hormone agonist | 0.063 0.005 DBMET00978 | ||
| 0.141 | 0.07 | 0.15 | Heat shock protein 70 antagonist | 0.15 0.046 DBMET00978 | DBMET00978 | |
| 0.075 | 0.004 | 0.075 | Guanylate cyclase inhibitor | 0.059 0.013 DBMET02315 0.069 0.005 DBMET00978 | ||
| 0.118 | 0.048 | 0.151 | DOPA decarboxylase inhibitor | 0.151 0.021 DBMET00978 | DBMET00978 | |
| 0.146 | 0.08 | 0.146 | Diuretic | 0.145 0.081 DBMET02315 0.119 0.106 DBMET00978 | ||
| 0.159 | 0.096 | 0.159 | Succinate dehydrogenase inhibitor | 0.153 0.107 DBMET00978 | ||
| 0.108 | 0.046 | 0.129 | Uric acid excretion stimulant | 0.129 0.033 DBMET02315 0.123 0.036 DBMET00978 | DBMET02315 | |
| 0.089 | 0.027 | 0.105 | MAP kinase kinase 7 inhibitor | 0.105 0.009 DBMET00978 | DBMET00978 | |
| 0.243 | 0.184 | 0.575 | Antibacterial | 0.575 0.023 DBMET02315 0.285 0.147 DBMET00978 | DBMET02315 | |
| 0.107 | 0.048 | 0.107 | HIV-1 integrase (Overall Integration) inhibitor | 0.097 0.057 DBMET00978 | ||
| 0.126 | 0.068 | 0.126 | Cholinergic antagonist | 0.123 0.071 DBMET00978 | ||
| 0.089 | 0.032 | 0.099 | Leukotriene synthesis inhibitor | 0.099 0.027 DBMET00978 | DBMET00978 | |
| 0.063 | 0.006 | 0.063 | 5-Alpha-reductase 2 inhibitor | 0.042 0.008 DBMET00978 | ||
| 0.06 | 0.005 | 0.06 | Glutamate (mGluR8) antagonist | 0.054 0.007 DBMET00978 | ||
| 0.123 | 0.068 | 0.123 | Acetylcholine antagonist | 0.12 0.07 DBMET00978 | ||
| 0.063 | 0.009 | 0.063 | GABA uptake inhibitor | 0.046 0.019 DBMET00978 | ||
| 0.108 | 0.056 | 0.108 | Adenylate kinase inhibitor | 0.091 0.084 DBMET00978 | ||
| 0.092 | 0.04 | 0.098 | Porphobilinogen synthase inhibitor | 0.098 0.037 DBMET00978 | DBMET00978 | |
| 0.102 | 0.052 | 0.102 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.088 0.068 DBMET02315 | ||
| 0.097 | 0.051 | 0.121 | Triose-phosphate isomerase inhibitor | 0.121 0.031 DBMET02315 0.081 0.073 DBMET00978 | DBMET02315 | |
| 0.075 | 0.03 | 0.075 | Glutamate (mGluR6) antagonist | 0.063 0.057 DBMET00978 | ||
| 0.109 | 0.067 | 0.164 | Cystathionine beta-synthase inhibitor | 0.164 0.035 DBMET00978 | DBMET00978 | |
| 0.12 | 0.079 | 0.141 | Tubulin antagonist | 0.141 0.062 DBMET00978 | DBMET00978 | |
| 0.096 | 0.059 | 0.104 | Bile acid receptor antagonist | 0.104 0.041 DBMET00978 | DBMET00978 | |
| 0.105 | 0.075 | 0.117 | Acetylcholine release stimulant | 0.117 0.053 DBMET02315 | DBMET02315 | |
| 0.133 | 0.105 | 0.189 | Interferon gamma antagonist | 0.189 0.045 DBMET02315 0.149 0.08 DBMET00978 | DBMET02315 | |
| 0.059 | 0.031 | 0.059 | Leukotriene C antagonist | 0.059 0.032 DBMET00978 | ||
| 0.069 | 0.044 | 0.069 | Glutamate (mGluR7) antagonist | |||
| 0.091 | 0.07 | 0.135 | Creatine kinase inhibitor | 0.135 0.031 DBMET00978 | DBMET00978 | |
| 0.071 | 0.051 | 0.071 | Phospholipase D inhibitor | |||
| 0.041 | 0.021 | 0.041 | Glutamate (mGluR8) agonist | 0.037 0.029 DBMET00978 | ||
| 0.198 | 0.178 | 0.292 | Vasodilator, peripheral | 0.292 0.101 DBMET02315 0.191 0.186 DBMET00978 | DBMET02315 | |
| 0.028 | 0.009 | 0.028 | 5-Alpha-reductase 1 inhibitor | 0.018 0.012 DBMET00978 | ||
| 0.052 | 0.034 | 0.052 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.078 | 0.06 | 0.088 | Glycine receptor antagonist | 0.088 0.045 DBMET02315 | DBMET02315 | |
| 0.094 | 0.078 | 0.094 | Ferrochelatase inhibitor | |||
| 0.139 | 0.123 | 0.139 | Lipocortins synthesis antagonist | |||
| 0.031 | 0.015 | 0.031 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.038 | 0.023 | 0.038 | Glutamate (mGluR3) antagonist | |||
| 0.023 | 0.008 | 0.023 | Follicle-stimulating hormone antagonist | 0.02 0.012 DBMET00978 | ||
| 0.075 | 0.062 | 0.075 | Histamine H1 receptor antagonist | |||
| 0.1 | 0.089 | 0.102 | Photosensitizer | 0.102 0.084 DBMET02315 0.098 0.093 DBMET00978 | DBMET02315 | |
| 0.068 | 0.057 | 0.084 | Glutamate decarboxylase inhibitor | 0.084 0.04 DBMET00978 | DBMET00978 | |
| 0.168 | 0.157 | 0.174 | RNA-directed DNA polymerase inhibitor | 0.168 0.156 DBMET02315 0.174 0.144 DBMET00978 | DBMET00978 | |
| 0.044 | 0.034 | 0.046 | Neuraminidase (Influenza A) inhibitor | 0.046 0.031 DBMET02315 0.044 0.035 DBMET00978 | DBMET02315 | |
| 0.038 | 0.029 | 0.038 | Leukotriene C4 antagonist | 0.038 0.031 DBMET00978 | ||
| 0.021 | 0.013 | 0.021 | Retinoid X beta receptor antagonist | |||
| 0.07 | 0.062 | 0.078 | GABA aminotransferase inhibitor | 0.078 0.05 DBMET00978 | DBMET00978 | |
| 0.124 | 0.117 | 0.124 | Pregnane X receptor agonist | |||
| 0.009 | 0.003 | 0.01 | Insulin like growth factor 3 antagonist | 0.01 0.003 DBMET00978 | DBMET00978 | |
| 0.041 | 0.035 | 0.041 | Sphingosine 1-phosphate receptor agonist | |||
| 0.015 | 0.01 | 0.015 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | 0.014 0.013 DBMET02315 0.015 0.01 DBMET00978 | ||
| 0.077 | 0.071 | 0.078 | Ornithine decarboxylase inhibitor | 0.078 0.069 DBMET00978 | DBMET00978 | |
| 0.097 | 0.092 | 0.113 | Cholesterol synthesis inhibitor | 0.113 0.072 DBMET00978 | DBMET00978 | |
| 0.032 | 0.027 | 0.032 | Free fatty acid receptor 1 antagonist | |||
| 0.051 | 0.047 | 0.051 | Dihydroorotate oxidase inhibitor | |||
| 0.144 | 0.142 | 0.148 | Insulin sensitizer | 0.148 0.136 DBMET00978 | DBMET00978 | |
| 0.097 | 0.096 | 0.18 | Microtubule formation inhibitor | 0.18 0.025 DBMET02315 | DBMET02315 | |
| 0.064 | 0.063 | 0.064 | Aminopeptidase I inhibitor | |||
| 0.206 | 0.207 | 0.291 | 15-Lipoxygenase inhibitor | 0.291 0.137 DBMET00978 | DBMET00978 | |
| 0.101 | 0.103 | 0.133 | Toll-Like receptor 2 antagonist | 0.133 0.065 DBMET00978 | DBMET00978 | |
| 0.062 | 0.065 | 0.066 | Protein kinase C beta inhibitor | 0.066 0.055 DBMET00978 | DBMET00978 | |
| 0.027 | 0.031 | 0.037 | Estrogen-related receptor alpha antagonist | 0.037 0.019 DBMET00978 | DBMET00978 | |
| 0.029 | 0.035 | 0.031 | Glutamate (mGluR3) agonist | 0.031 0.026 DBMET00978 | DBMET00978 | |
| 0.037 | 0.043 | 0.039 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.039 0.035 DBMET00978 | DBMET00978 | |
| 0.081 | 0.088 | 0.153 | UDP-glucose 4-epimerase inhibitor | 0.153 0.028 DBMET02315 | DBMET02315 | |
| 0.077 | 0.086 | 0.097 | Prolactin inhibitor | 0.097 0.059 DBMET00978 | DBMET00978 | |
| 0.067 | 0.078 | 0.075 | GABA B receptor agonist | 0.075 0.055 DBMET00978 | DBMET00978 | |
| 0.034 | 0.045 | 0.045 | NMDA receptor subunit 3B antagonist | 0.045 0.029 DBMET00978 | DBMET00978 | |
| 0.087 | 0.099 | 0.095 | Mucolytic | 0.095 0.085 DBMET00978 | DBMET00978 | |
| 0.075 | 0.087 | 0.132 | NADH dehydrogenase inhibitor | 0.132 0.023 DBMET02315 | DBMET02315 | |
| 0.027 | 0.041 | 0.037 | NMDA receptor subunit 3A antagonist | 0.037 0.028 DBMET00978 | DBMET00978 | |
| 0.132 | 0.148 | 0.146 | Phospholipase C inhibitor | 0.146 0.114 DBMET00978 | DBMET00978 | |
| 0.052 | 0.068 | 0.055 | Ryanodine receptor antagonist | 0.055 0.053 DBMET00978 | DBMET00978 | |
| 0.029 | 0.047 | 0.032 | Protein kinase C beta I inhibitor | 0.032 0.029 DBMET02315 | DBMET02315 | |
| 0.055 | 0.076 | 0.1 | Na+ K+ transporting ATPase inhibitor | 0.1 0.032 DBMET02315 | DBMET02315 | |
| 0.109 | 0.131 | 0.139 | Farnesoid X receptor antagonist | 0.139 0.067 DBMET00978 | DBMET00978 | |
| 0.032 | 0.056 | 0.048 | NMDA 2A receptor antagonist | 0.048 0.04 DBMET00978 | DBMET00978 | |
| 0.039 | 0.065 | 0.055 | Alcohol oxidase inhibitor | 0.055 0.04 DBMET00978 | DBMET00978 | |
| 0.048 | 0.075 | 0.094 | Lipase inhibitor | 0.094 0.031 DBMET02315 0.068 0.056 DBMET00978 | DBMET02315 | |
| 0.015 | 0.043 | 0.028 | Squalene synthetase inhibitor | 0.028 0.026 DBMET02315 | DBMET02315 | |
| 0.13 | 0.159 | 0.149 | Neurotensin receptor agonist | 0.149 0.103 DBMET00978 | DBMET00978 | |
| 0.039 | 0.071 | 0.055 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.055 0.035 DBMET00978 | DBMET00978 | |
| 0.024 | 0.057 | 0.046 | Estradiol 17 beta-dehydrogenase inhibitor | 0.046 0.027 DBMET00978 | DBMET00978 | |
| 0.018 | 0.054 | 0.046 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.046 0.018 DBMET00978 | DBMET00978 | |
| 0.147 | 0.186 | 0.475 | Hypoglycemic | 0.475 0.018 DBMET02315 0.188 0.125 DBMET00978 | DBMET02315 | |
| 0.042 | 0.083 | 0.083 | Phosphofructokinase-1 inhibitor | 0.083 0.039 DBMET02315 | DBMET02315 | |
| 0.07 | 0.115 | 0.077 | CC chemokine 5 receptor agonist | 0.077 0.076 DBMET00978 | DBMET00978 | |
| 0.11 | 0.155 | 0.385 | Nitric oxide antagonist | 0.385 0.027 DBMET02315 0.142 0.102 DBMET00978 | DBMET02315 | |
| 0.103 | 0.149 | 0.12 | Hexokinase inhibitor | 0.12 0.118 DBMET02315 | DBMET02315 | |
| 0.184 | 0.23 | 0.221 | GABA C receptor rho-3 antagonist | 0.221 0.182 DBMET00978 | DBMET00978 | |
| 0.056 | 0.106 | 0.069 | Keratolytic | 0.069 0.066 DBMET00978 | DBMET00978 | |
| 0.067 | 0.12 | 0.147 | Expectorant | 0.147 0.036 DBMET02315 | DBMET02315 | |
| 0.1 | 0.154 | 0.12 | Papain-like protease (SARS coronavirus) inhibitor | 0.12 0.082 DBMET00978 | DBMET00978 | |
| 0.032 | 0.088 | 0.047 | Glucose-6-phosphate isomerase inhibitor | 0.047 0.034 DBMET02315 | DBMET02315 | |
| 0.044 | 0.104 | 0.06 | Neuraminidase (influenza) inhibitor | 0.06 0.053 DBMET02315 | DBMET02315 | |
| 0.042 | 0.103 | 0.062 | Adenine nucleotide translocase inhibitor | 0.062 0.025 DBMET02315 | DBMET02315 | |
| 0.068 | 0.137 | 0.123 | DNA polymerase I inhibitor | 0.123 0.066 DBMET02315 0.095 0.091 DBMET00978 | DBMET02315 | |
| 0.116 | 0.198 | 0.148 | Neurotrophic factor enhancer | 0.148 0.141 DBMET00978 | DBMET00978 | |
| 0.066 | 0.153 | 0.164 | AMP-activated protein kinase stimulant | 0.164 0.02 DBMET02315 | DBMET02315 | |
| 0.054 | 0.141 | 0.07 | Estrogen receptor alpha antagonist | 0.07 0.067 DBMET00978 | DBMET00978 | |
| 0.16 | 0.249 | 0.239 | Sodium/bile acid cotransporter inhibitor | 0.239 0.14 DBMET00978 | DBMET00978 | |
| 0.021 | 0.111 | 0.055 | Mannosidase inhibitor | 0.055 0.02 DBMET02315 | DBMET02315 | |
| 0.028 | 0.12 | 0.064 | Alpha-mannosidase inhibitor | 0.064 0.022 DBMET02315 | DBMET02315 | |
| 0.051 | 0.147 | 0.08 | Cell adhesion molecule inhibitor | 0.08 0.053 DBMET02315 | DBMET02315 | |
| 0.031 | 0.127 | 0.08 | Glucose-6-phosphate translocase inhibitor | 0.08 0.011 DBMET02315 | DBMET02315 | |
| 0.071 | 0.17 | 0.148 | Cyclooxygenase 3 inhibitor | 0.148 0.05 DBMET02315 | DBMET02315 | |
| 0.059 | 0.162 | 0.121 | Estrogen receptor beta antagonist | 0.121 0.031 DBMET00978 | DBMET00978 | |
| 0.128 | 0.235 | 0.18 | Lipoxygenase inhibitor | 0.18 0.163 DBMET00978 | DBMET00978 | |
| 0.008 | 0.116 | 0.02 | Corticosteroid-like | 0.02 0.017 DBMET02315 | DBMET02315 | |
| 0.009 | 0.124 | 0.02 | Antibiotic Anthracycline-like | 0.02 0.012 DBMET02315 | DBMET02315 | |
| 0.025 | 0.142 | 0.063 | Protein kinase C eta inhibitor | 0.063 0.032 DBMET02315 | DBMET02315 | |
| 0.067 | 0.195 | 0.13 | Estrogen antagonist | 0.13 0.038 DBMET00978 | DBMET00978 | |
| 0.028 | 0.157 | 0.06 | Heparanase inhibitor | 0.06 0.023 DBMET02315 | DBMET02315 | |
| 0.091 | 0.228 | 0.201 | Hypolipemic | 0.201 0.093 DBMET02315 | DBMET02315 | |
| 0.043 | 0.188 | 0.135 | Mediator release inhibitor | 0.135 0.036 DBMET02315 | DBMET02315 | |
| 0.053 | 0.199 | 0.202 | Amylase inhibitor | 0.202 0.044 DBMET02315 | DBMET02315 | |
| 0.074 | 0.221 | 0.146 | Cell wall synthesis inhibitor | 0.146 0.069 DBMET02315 | DBMET02315 | |
| 0.095 | 0.242 | 0.26 | Spasmolytic | 0.26 0.087 DBMET02315 | DBMET02315 | |
| 0.037 | 0.209 | 0.058 | Lipocortins synthesis agonist | 0.058 0.039 DBMET02315 | DBMET02315 | |
| 0.017 | 0.199 | 0.12 | Antineoplastic antibiotic | 0.12 0.039 DBMET02315 | DBMET02315 | |
| 0.017 | 0.207 | 0.081 | Protein 50S ribosomal subunit inhibitor | 0.081 0.019 DBMET02315 | DBMET02315 | |
| 0.043 | 0.248 | 0.115 | Beta glucuronidase inhibitor | 0.115 0.051 DBMET02315 | DBMET02315 | |
| 0.036 | 0.243 | 0.09 | ATPase (Vacuolar H+) inhibitor | 0.09 0.055 DBMET02315 | DBMET02315 | |
| 0.056 | 0.263 | 0.127 | Cell adhesion inhibitor | 0.127 0.06 DBMET02315 | DBMET02315 | |
| 0.023 | 0.239 | 0.088 | Monophenol monooxygenase inhibitor | 0.088 0.085 DBMET02315 | DBMET02315 | |
| 0.093 | 0.321 | 0.458 | Transcription factor NF kappa B inhibitor | 0.458 0.051 DBMET02315 | DBMET02315 | |
| 0.07 | 0.301 | 0.17 | Hemostatic | 0.17 0.048 DBMET02315 | DBMET02315 | |
| 0.067 | 0.299 | 0.368 | Hepatoprotectant | 0.368 0.016 DBMET02315 | DBMET02315 | |
| 0.159 | 0.394 | 0.261 | Caspase 9 stimulant | 0.261 0.24 DBMET02315 | DBMET02315 | |
| 0.083 | 0.319 | 0.135 | ATPase inhibitor | 0.135 0.131 DBMET02315 | DBMET02315 | |
| 0.068 | 0.311 | 0.449 | Free radical scavenger | 0.449 0.022 DBMET02315 0.171 0.123 DBMET00978 | DBMET02315 | |
| 0.093 | 0.356 | 0.129 | CC chemokine 6 receptor antagonist | 0.129 0.075 DBMET02315 | DBMET02315 | |
| 0.071 | 0.335 | 0.48 | Antioxidant | 0.48 0.022 DBMET02315 0.167 0.146 DBMET00978 | DBMET02315 | |
| 0.013 | 0.278 | 0.041 | Microtubule stabilization | 0.041 0.039 DBMET02315 | DBMET02315 | |
| 0.107 | 0.381 | 0.327 | Peptidyltransferase inhibitor | 0.327 0.017 DBMET02315 | DBMET02315 | |
| 0.021 | 0.307 | 0.058 | Factor IXa inhibitor | 0.058 0.028 DBMET02315 | DBMET02315 | |
| 0.006 | 0.293 | 0.024 | Sodium/glucose cotransporter inhibitor | 0.024 0.021 DBMET02315 | DBMET02315 | |
| 0.027 | 0.321 | 0.119 | Topoisomerase II inhibitor | 0.119 0.068 DBMET02315 | DBMET02315 | |
| 0.05 | 0.35 | 0.334 | Immunostimulant | 0.334 0.069 DBMET02315 | DBMET02315 | |
| 0.011 | 0.329 | 0.275 | Selectin antagonist | 0.275 0.007 DBMET02315 | DBMET02315 | |
| 0.03 | 0.361 | 0.193 | Thrombolytic | 0.193 0.055 DBMET02315 | DBMET02315 | |
| 0.061 | 0.406 | 0.337 | Alpha-glucosidase inhibitor | 0.337 0.142 DBMET02315 | DBMET02315 | |
| 0.031 | 0.377 | 0.191 | Lipid peroxidase inhibitor | 0.191 0.046 DBMET02315 | DBMET02315 | |
| 0.039 | 0.39 | 0.133 | Transcription factor NF kappa B stimulant | 0.133 0.02 DBMET02315 | DBMET02315 | |
| 0.014 | 0.365 | 0.059 | Antibiotic Aminoglycoside-like | 0.059 0.009 DBMET02315 | DBMET02315 | |
| 0.053 | 0.421 | 0.11 | DNA repair enzyme inhibitor | 0.11 0.095 DBMET02315 | DBMET02315 | |
| 0.012 | 0.409 | 0.028 | Toll-Like receptor 4 agonist | 0.028 0.015 DBMET02315 | DBMET02315 | |
| 0.084 | 0.484 | 0.396 | Apoptosis antagonist | 0.396 0.039 DBMET02315 | DBMET02315 | |
| 0.017 | 0.419 | 0.145 | Topoisomerase I inhibitor | 0.145 0.043 DBMET02315 | DBMET02315 | |
| 0.042 | 0.449 | 0.27 | Vasodilator | 0.27 0.059 DBMET02315 | DBMET02315 | |
| 0.041 | 0.463 | 0.183 | Insulin secretagoues | 0.183 0.046 DBMET02315 | DBMET02315 | |
| 0.005 | 0.451 | 0.03 | Protein 30S ribosomal subunit inhibitor | 0.03 0.013 DBMET02315 | DBMET02315 | |
| 0.029 | 0.477 | 0.139 | Toll-Like receptor 4 antagonist | 0.139 0.027 DBMET02315 | DBMET02315 | |
| 0.044 | 0.506 | 0.159 | NOS3 expression enhancer | 0.159 0.064 DBMET02315 | DBMET02315 | |
| 0.034 | 0.515 | 0.377 | Platelet adhesion inhibitor | 0.377 0.014 DBMET02315 | DBMET02315 | |
| 0.021 | 0.525 | 0.146 | Anticoagulant | 0.146 0.084 DBMET02315 | DBMET02315 | |
| 0.04 | 0.735 | 0.217 | Caspase 3 stimulant | 0.217 0.146 DBMET02315 | DBMET02315 | |
| 0.008 | 0.831 | 0.244 | Tumour necrosis factor alpha release inhibitor | 0.244 0.077 DBMET02315 | DBMET02315 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |